Non-viral ex vivo genome-editing in mouse bona fide hematopoietic stem cells with CRISPR/Cas9

We conducted two lines of genome-editing experiments of mouse hematopoietic stem cells (HSCs) with the clustered regularly interspaced short palindromic repeat (CRISPR) and CRISPR-associated protein 9 (Cas9). First, to evaluate the genome-editing efficiency in mouse bona fide HSCs, we knocked out in...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Mol Ther Methods Clin Dev
Autores principales: Byambaa, Suvd, Uosaki, Hideki, Ohmori, Tsukasa, Hara, Hiromasa, Endo, Hitoshi, Nureki, Osamu, Hanazono, Yutaka
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Gene & Cell Therapy 2021
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7873578/
https://ncbi.nlm.nih.gov/pubmed/33614821
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omtm.2021.01.001
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares